John A Fisher

Practice Areas

John Fisher is a founding partner of Freshfields’ Silicon Valley office and Head of U.S. Technology and Life Sciences M&A. John advises some of Silicon Valley’s most innovative and pioneering companies in their technology and life sciences mergers, acquisitions and joint ventures. He additionally acts as regular counsel to both US and international clients as they enter the Silicon Valley market or partner with established Silicon Valley companies.

John’s recent deals include representing AstraZeneca on its $39 billion acquisition of Alexion Pharmaceuticals, Ericsson on the sale of its IoT Accelerator and Connected Vehicle Cloud businesses, Siemens on its $700 million acquisition of Supplyframe, Axel Springer on its acquisition of POLITICO, TriNet on its acquisition of Clarus R+D Solutions, Agilent Technologies on its acquisition of Resolution Bioscience for $550 million in cash at closing and up to an additional $145 million based on achieving future performance milestones, Fresenius Helios on its $550 million acquisition of leading international fertility company Eugin Group from NMC Health, Zymergen on various M&A matters including its acquisition of Lodo Therapeutics, and Salesforce on its $1.33 billion acquisition of cloud and mobile software provider Vlocity.

Career

Columbia School of Law, J.D., 2004 Harlan Fiske Stone Scholar

Senior Editor, Columbia Law Review

Harvard University, B.A. in Biochemical Sciences, 1999

Professional Memberships

Member of the California Bar

Member of the New York Bar

Bay Area Lawyers for Individual Freedom (BALIF)